The Ups and Downs of Precision Medicine
Acredit’s Anne Hansen Ree has penned a new article looking into the use of precision medicine in cancer. In it,
Read more
MetAction
Molecularly Matched Therapy and Outcomes in End-Stage Cancers
Lead Acredit professors Anne Hansen Ree and Kjersti Flatmark have published a paper outlining the final results from the MetAction
Read moreMetAction in the News
On the 3rd of April 2018, VG (a well-known Norwegian newspaper) ran a two-page article about the MetAction trial currently
Read more